(S)-N,N-Diisopropyldinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin-4-amine, 98.0%, 1g

(4-(tert-Butyl)phenyl)(imino)(methyl)-l6-sulfanone, 1g

N-(5-((2R,4R,5R)-5-((bis(4-methoxyphenyl)(phenyl)methoxy)methyl)-4-hydroxytetrahydrofuran-2-yl)-3-nitro-6-(4-nitrophenethoxy)pyridin-2-yl)acetamide, 98%, 1g

O-(3,6,9,12-Tetraoxapentadec-14-yn-1-yl)hydroxylamine, 95%, 1g

(S)-1-Boc-2,2-Dimethyl-4-hydroxymethyl-oxazolidine, 95.0%, 5g

4-CHLORO-2-METHYL-5-(TRIFLUOROMETHYL)ANILINE, 95.0%, 10g

(S)-3-(tert-Butyldimethylsilyloxy) pyrrolidine, 95.0%, 5g

[4-(2-Hydroxy-ethylamino)-cyclohexyl]-methyl-carbamic acid tert-butyl ester, 500mg

Potassium bromate, = 99.8% (Titration: anhydrous basis), 1kg

1-(4-Amino-2-chlorophenyl)-4-methylpiperazine trihydrochloride, 95.0%, 1g

3-(Methoxycarbonyl)pyrazolo[1,5-a]pyridine-2-carboxylic acid, 95.0%, 1g

1,3,6,8-Tetraethynyl-9H-carbazole, 97%, 100mg

2-CHLORO-6-METHOXYQUINAZOLIN-4-AMINE, 95%, 1g